Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20658227 | 0.90 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL8069328 | 0.90 | MEN1 (0.39) | TSHRTDP1HSD17B10MAPK1 | |
| SCHEMBL8057662 | 0.90 | MEN1 (0.39) | TSHRTDP1HSD17B10MAPK1 | |
| SCHEMBL242589 | 0.87 | — | — | |
| SCHEMBL1828124 | 0.85 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL27503939 | 0.85 | — | — | |
| SCHEMBL10356415 | 0.83 | DNM1 (0.36) | TDP1HSD17B10 | |
| SCHEMBL14814280 | 0.83 | — | — | |
| SCHEMBL14814294 | 0.83 | — | — | |
| SCHEMBL17656329 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018108256-A1 | COMPOSITION FOR DRESSING CUTANEOUS LESIONS AND MANUFACTURING METHOD THEREOF | STAHL KURT WILHELM (DE) | 2018-06-21 | — | — | WO | disclosed |
| CN-101687338-B | Preservative compositions for wood and like materials | GENICS INC | 2014-08-20 | — | — | CN | disclosed |
| US-20100144890-A1 | USE OF A SURFACTANT FOR THE PREPARATION OF A FORMULATION FOR THE TREATMENT OF ADIPOSE DISEASES | BODERKE PETER | 2010-06-10 | — | — | US | disclosed |
| CN-101687338-A | Preservative compositions for wood and like materials | GENICS INC | 2010-03-31 | — | — | CN | disclosed |
| US-6027854-A | ACTINIC RADIATION-SENSITIVE, CROSSLINKED TERPOLYMER CONTAINING STYRENIC GROUPS RING-SUBSTITUTED WITH HYDROXYL, HYDROXYALKYLOXY, CARBOXYALKYLOXY MOIETIES AND ACID LABILE GROUPS; ETCHING AND HEAT RESISTANCE | SHIN-ETSU CHEMICAL CO., LTD. | 2000-02-22 | — | — | US | disclosed |
| US-4739042-A | ESTERIFICATION OF AN HYDROXY PYRIDONE DYESTUFF WITH CARBOXYLIC PYRIDINE DYESTUFF | BAYER AKTIENGESELLSCHAFT (DE) | 1988-04-19 | — | — | US | disclosed |
| US-4514227-A | Method of manufacturing a foundry mould mix containing a mould binder | CANADIAN PATENTS AND DEVELOPMENT LIMITED (CA) | 1985-04-30 | — | — | US | disclosed |
| US-4509983-A | USING ORGANIC ACID AND CALCIUM CARBONATE PRECIPITANT | CANADIAN PATENTS AND DEVELOPMENT LIMITED (CA) | 1985-04-09 | — | — | US | disclosed |
| EP-0083477-A1 | A method of manufacturing a foundry mould mix containing binder components and mould binder components therefor | Canadian Patents and Development Limited (CA) | 1983-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144890-A1 | USE OF A SURFACTANT FOR THE PREPARATION OF A FORMULATION FOR THE TREATMENT OF ADIPOSE DISEASES | FABP4, PNLIP, LIPE | ALDH1A1 1810/4885LMNA 600/4885TSHR 887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.